The LLS Blog

Burlington Launches Point of Sale Campaign to Benefit LLS September - December

By LLS Staff | September, 2019

"A Style for Every Smile” – LLS Kicks Off National PR Campaign to Support #1 Partner Burlington

For the 18th consecutive year, The Leukemia & Lymphoma Society (LLS) has teamed up with Burlington Stores to raise critical funds for research and patient support to help to save lives and bring smiles to the faces of children and families impacted by blood cancer. From September 9 through December 2, 2019, Burlington Stores nationwide will encourage its customers to donate $1 or more at checkout to support LLS’s goal to create a world without blood cancer.

This year, CFDA designer Christian Siriano, joined the campaign to help young cancer survivors find great fashions that suit their personal style with looks from Burlington. On September 17, LLS & Burlington kicked off officially our PR campaign to support our number one National Corporate Partner and Honored Friend at Burlington’s flagship store in New York City, with CFDA designer Christian Siriano, who outfitted young cancer survivors with fashions that match their personal style while providing his professional tips for the season.

Similar events will take place in Burlington stores across the country for our second annual surprise and delight campaign called “A Style for Every Smile” – bringing smiles to even more deserving kids by surprising them with a Burlington gift card at an in-store shopping spree event. Knowing that thousands of school-age children are diagnosed with blood cancers each year, this important initiative provides young survivors the opportunity to shop and showcase their own personal style, giving them the confidence they need to return to school and friends.

“Burlington is our number one National Corporate Partner and Honored Friend of The Leukemia & Lymphoma Society, having raised more than $37 million for the cause. LLS is a global leader in the fight to end blood cancer, and partners like Burlington have helped us invest nearly $1.3 billion in breakthrough research to advance lifesaving treatments and cures,” said Louis J. DeGennaro, PhD, LLS president and chief executive officer. “LLS is doubling our investment in fighting pediatric cancers, and we are proud to partner with our friends at Burlington who bring smiles to so many children and families. Together, we are closer than ever to cures.”

NBC’s TODAY Show’s Hoda Kotb Highlights LLS Children’s Initiative

By LLS Staff | September, 2019

We’re delighted to share that Dr. Lou was on NBC’s TODAY show speaking about LLS’s dedication to finding new ways to treat pediatric cancer through The LLS Children’s Initiative.

Young cancer survivor Austin Schuetz from Falls River, WI, and his family were featured in the piece.  At five years old, Austin had been dealing with leukemia for the majority of his young life. His parents enrolled him into a clinical trial; it was their only hope. The pioneering therapy administered was CAR T-cell immunotherapy.

WATCH FULL VIDEO

Sailing In One Direction to End Childhood Cancer

By Andrea Greif | September, 2019

In the treatment of children with acute myeloid leukemia “We have plateaued. The tools in our toolbox are all sledgehammers.”

This grim assessment was how Dr. E. Anders Kolb, of Nemours/Alfred I DuPont Hospital for Children, characterized the state of treatment for children with this devastating form of leukemia.

Dr. Kolb was among a group of pediatric oncologists to join The Leukemia & Lymphoma Society (LLS) in hosting an event in Atlanta this week to discuss LLS’s new $50 million Children’s Initiative, a multi-faceted effort to:

• double our investment in research;
• expand support services for patients and families;
• and launch a major collaborative clinical trial in acute leukemia

LLS is leading the charge to fundamentally change how we treat and care for children with blood cancer. But we can’t do it alone.  The audience for the Atlanta event was approximately 80 parents and advocates from foundations focused on children touched by blood cancer. They heard from a panel of doctors who have joined with LLS Chief Medical Officer Dr. Gwen Nichols to develop and implement a bold global LLS-led clinical trial to bring precision medicine to children with acute leukemia. The attendees participated in a spirited discussion about how they can get involved and help.